180 related articles for article (PubMed ID: 20851537)
1. Challenges in immunisation against bacterial infection in children.
Trück J; Pollard AJ
Early Hum Dev; 2010 Nov; 86(11):695-701. PubMed ID: 20851537
[TBL] [Abstract][Full Text] [Related]
2. Sustaining immunity after immunization against encapsulated bacteria.
Blanchard-Rohner G; Pollard AJ
Hum Vaccin; 2008; 4(4):309-12. PubMed ID: 18398302
[TBL] [Abstract][Full Text] [Related]
3. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
Blanchard-Rohner G; Pollard AJ
Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
[TBL] [Abstract][Full Text] [Related]
4. Challenges for development of meningococcal vaccines in infants and children.
Deasy A; Read RC
Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
[TBL] [Abstract][Full Text] [Related]
5. Bacterial polysaccharide-protein conjugate vaccines.
Finn A
Br Med Bull; 2004; 70():1-14. PubMed ID: 15339854
[TBL] [Abstract][Full Text] [Related]
6. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination.
Trotter CL; Gay NJ; Edmunds WJ
Am J Epidemiol; 2005 Jul; 162(1):89-100. PubMed ID: 15961591
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
[TBL] [Abstract][Full Text] [Related]
8. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.
Slack MH; Schapira D; Thwaites RJ; Burrage M; Southern J; Andrews N; Borrow R; Goldblatt D; Miller E
J Infect Dis; 2001 Dec; 184(12):1617-20. PubMed ID: 11740740
[TBL] [Abstract][Full Text] [Related]
9. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.
MacLennan J; Obaro S; Deeks J; Lake D; Elie C; Carlone G; Moxon ER; Greenwood B
J Infect Dis; 2001 Jan; 183(1):97-104. PubMed ID: 11087205
[TBL] [Abstract][Full Text] [Related]
10. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
[TBL] [Abstract][Full Text] [Related]
11. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.
Ahonkhai VI; Lukacs LJ; Jonas LC; Matthews H; Vella PP; Ellis RW; Staub JM; Dolan KT; Rusk CM; Calandra GB
Pediatrics; 1990 Apr; 85(4 Pt 2):676-81. PubMed ID: 2107518
[TBL] [Abstract][Full Text] [Related]
12. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
[TBL] [Abstract][Full Text] [Related]
13. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
Yogev R; Tan T
Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
[TBL] [Abstract][Full Text] [Related]
14. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
15. [Conjugated vaccines].
Swennen B; Sternon J
Rev Med Brux; 2002 Jun; 23(3):165-74. PubMed ID: 12143156
[TBL] [Abstract][Full Text] [Related]
16. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
[TBL] [Abstract][Full Text] [Related]
17. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
Walter EB; Moggio MV; Drucker RP; Wilfert CM
Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
20. Neisseria meningitidis B vaccines.
Panatto D; Amicizia D; Lai PL; Gasparini R
Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
